

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hepatocyte apoptotic process (GO:0097284) | 5.48867681 |
| 2 | protein K11-linked deubiquitination (GO:0035871) | 5.26447280 |
| 3 | interferon-gamma production (GO:0032609) | 4.90328293 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.87459921 |
| 5 | histone H3-K36 demethylation (GO:0070544) | 4.81237689 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.54858212 |
| 7 | nuclear pore complex assembly (GO:0051292) | 4.50701462 |
| 8 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.50668469 |
| 9 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.49283139 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.36004462 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.36004462 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.16175923 |
| 13 | protein K48-linked deubiquitination (GO:0071108) | 4.15194996 |
| 14 | histone mRNA catabolic process (GO:0071044) | 3.97470708 |
| 15 | rRNA catabolic process (GO:0016075) | 3.83575035 |
| 16 | cellular response to ethanol (GO:0071361) | 3.76996340 |
| 17 | nuclear pore organization (GO:0006999) | 3.73726757 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.66624453 |
| 19 | positive regulation of granulocyte differentiation (GO:0030854) | 3.64133451 |
| 20 | establishment of protein localization to vacuole (GO:0072666) | 3.60236754 |
| 21 | protein targeting to vacuole (GO:0006623) | 3.60236754 |
| 22 | protein targeting to lysosome (GO:0006622) | 3.60236754 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 3.57778004 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.49642373 |
| 25 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.48438890 |
| 26 | positive T cell selection (GO:0043368) | 3.44524808 |
| 27 | dosage compensation (GO:0007549) | 3.42887198 |
| 28 | pericardium development (GO:0060039) | 3.41788655 |
| 29 | histone H3-K4 trimethylation (GO:0080182) | 3.41755766 |
| 30 | response to interleukin-15 (GO:0070672) | 3.41281334 |
| 31 | negative T cell selection (GO:0043383) | 3.41135101 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.37244045 |
| 33 | protein K63-linked deubiquitination (GO:0070536) | 3.35702861 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32048907 |
| 35 | negative thymic T cell selection (GO:0045060) | 3.24502252 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.24267194 |
| 37 | myeloid leukocyte mediated immunity (GO:0002444) | 3.22975477 |
| 38 | pore complex assembly (GO:0046931) | 3.22500434 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19185235 |
| 40 | histone-serine phosphorylation (GO:0035404) | 3.15991925 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.12710504 |
| 42 | natural killer cell activation involved in immune response (GO:0002323) | 3.12217481 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12029785 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.10980006 |
| 45 | interkinetic nuclear migration (GO:0022027) | 3.09647269 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05890878 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.00657471 |
| 48 | peptidyl-lysine trimethylation (GO:0018023) | 2.99964955 |
| 49 | microglial cell activation (GO:0001774) | 2.99503183 |
| 50 | cellular extravasation (GO:0045123) | 2.96661231 |
| 51 | muscle atrophy (GO:0014889) | 2.96237328 |
| 52 | striated muscle atrophy (GO:0014891) | 2.95502433 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93208025 |
| 54 | establishment of protein localization to Golgi (GO:0072600) | 2.90876091 |
| 55 | negative regulation of DNA repair (GO:0045738) | 2.88452532 |
| 56 | replicative senescence (GO:0090399) | 2.85335846 |
| 57 | positive regulation of developmental pigmentation (GO:0048087) | 2.84723325 |
| 58 | mast cell degranulation (GO:0043303) | 2.84311906 |
| 59 | mast cell activation involved in immune response (GO:0002279) | 2.84311906 |
| 60 | mast cell activation (GO:0045576) | 2.83719566 |
| 61 | prenylation (GO:0097354) | 2.83254717 |
| 62 | protein prenylation (GO:0018342) | 2.83254717 |
| 63 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81772666 |
| 64 | skeletal muscle adaptation (GO:0043501) | 2.80014704 |
| 65 | negative regulation of B cell proliferation (GO:0030889) | 2.78022903 |
| 66 | regulation of necroptotic process (GO:0060544) | 2.76793730 |
| 67 | macrophage activation (GO:0042116) | 2.76095131 |
| 68 | alpha-beta T cell activation (GO:0046631) | 2.75647249 |
| 69 | histone H3-K4 methylation (GO:0051568) | 2.72981467 |
| 70 | negative regulation of myotube differentiation (GO:0010832) | 2.70600271 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.68395189 |
| 72 | mitochondrion distribution (GO:0048311) | 2.67931787 |
| 73 | histone H4-K16 acetylation (GO:0043984) | 2.67384553 |
| 74 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.64993091 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.64848094 |
| 76 | neural tube formation (GO:0001841) | 2.62857472 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.60641592 |
| 78 | T cell selection (GO:0045058) | 2.57436820 |
| 79 | peptidyl-lysine methylation (GO:0018022) | 2.57051599 |
| 80 | energy homeostasis (GO:0097009) | 2.56126278 |
| 81 | T cell migration (GO:0072678) | 2.55853610 |
| 82 | mature B cell differentiation (GO:0002335) | 2.55276836 |
| 83 | fibroblast migration (GO:0010761) | 2.54955123 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.54200062 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.52093840 |
| 86 | leukocyte degranulation (GO:0043299) | 2.50577569 |
| 87 | tryptophan metabolic process (GO:0006568) | 2.49882161 |
| 88 | ncRNA catabolic process (GO:0034661) | 2.49830605 |
| 89 | adenosine metabolic process (GO:0046085) | 2.49770306 |
| 90 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.49674257 |
| 91 | negative regulation of TOR signaling (GO:0032007) | 2.49335298 |
| 92 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.48986589 |
| 93 | regulation of B cell differentiation (GO:0045577) | 2.48391696 |
| 94 | regulation of pigment cell differentiation (GO:0050932) | 2.48102778 |
| 95 | cAMP catabolic process (GO:0006198) | 2.47944431 |
| 96 | pre-miRNA processing (GO:0031054) | 2.47184771 |
| 97 | T cell proliferation (GO:0042098) | 2.47054230 |
| 98 | DNA demethylation (GO:0080111) | 2.47006644 |
| 99 | protein destabilization (GO:0031648) | 2.46393198 |
| 100 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.45691048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.96805979 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.13294592 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.87792309 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68490014 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.67454430 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.55596354 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.39279054 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.78268713 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.70033410 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.44170878 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34115977 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30290153 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25409811 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22291861 |
| 15 | TP53_16413492_ChIP-PET_HCT116_Human | 2.20565511 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12146742 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10652719 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05431442 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.97897452 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91568356 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84824035 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.77442961 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75090225 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.63861892 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59429949 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57461790 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54695926 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53374060 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51498530 |
| 30 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51117449 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47339531 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.44587952 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44031115 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41588449 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40586699 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36276842 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35850191 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35710221 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32503185 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31789647 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30311329 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28996560 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28872652 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28221129 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25529207 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24410980 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22576547 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20093829 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19981038 |
| 50 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19612984 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17553230 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14708176 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14201560 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12704728 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12392095 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12392095 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12345521 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12339440 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11477148 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10811607 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09718276 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09455618 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08537787 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07779978 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07414882 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07372582 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07062122 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03304832 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03163634 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02921260 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02315962 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02217130 |
| 73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02087499 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01566297 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00112100 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00085114 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99962099 |
| 78 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99671070 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99373464 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98961938 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98774428 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97806695 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97598224 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97441742 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96597938 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.96528616 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96134874 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95986527 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95629366 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94894021 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94487918 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94011513 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93013020 |
| 94 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92668871 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92039480 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 0.91855497 |
| 97 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.90737941 |
| 98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90269214 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89794891 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89501595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.38705322 |
| 2 | MP0008057_abnormal_DNA_replication | 4.67968985 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.38514257 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.99479439 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.81695038 |
| 6 | MP0003724_increased_susceptibility_to | 2.62558056 |
| 7 | MP0005075_abnormal_melanosome_morpholog | 2.62021835 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.18371669 |
| 9 | MP0004043_abnormal_pH_regulation | 2.12840275 |
| 10 | MP0001800_abnormal_humoral_immune | 2.12818902 |
| 11 | MP0004808_abnormal_hematopoietic_stem | 2.01243964 |
| 12 | MP0003646_muscle_fatigue | 1.97148615 |
| 13 | MP0004130_abnormal_muscle_cell | 1.90531577 |
| 14 | MP0003828_pulmonary_edema | 1.89991966 |
| 15 | MP0004381_abnormal_hair_follicle | 1.81231992 |
| 16 | MP0000371_diluted_coat_color | 1.81223875 |
| 17 | MP0002009_preneoplasia | 1.80541273 |
| 18 | MP0000383_abnormal_hair_follicle | 1.77790642 |
| 19 | MP0005671_abnormal_response_to | 1.76967697 |
| 20 | MP0010094_abnormal_chromosome_stability | 1.75666096 |
| 21 | MP0000685_abnormal_immune_system | 1.74811242 |
| 22 | MP0004233_abnormal_muscle_weight | 1.73247542 |
| 23 | MP0002398_abnormal_bone_marrow | 1.71430433 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.70118793 |
| 25 | MP0008995_early_reproductive_senescence | 1.69831364 |
| 26 | MP0000703_abnormal_thymus_morphology | 1.66531455 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.64515482 |
| 28 | MP0005083_abnormal_biliary_tract | 1.63028859 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.57958299 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.56861933 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.55926109 |
| 32 | MP0002722_abnormal_immune_system | 1.53316744 |
| 33 | MP0003890_abnormal_embryonic-extraembry | 1.52724355 |
| 34 | MP0002723_abnormal_immune_serum | 1.52598292 |
| 35 | MP0008058_abnormal_DNA_repair | 1.50550336 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.50538116 |
| 37 | MP0001819_abnormal_immune_cell | 1.47544862 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.47414860 |
| 39 | MP0001661_extended_life_span | 1.46401679 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.45848930 |
| 41 | MP0000716_abnormal_immune_system | 1.45454782 |
| 42 | MP0003786_premature_aging | 1.44170984 |
| 43 | MP0002405_respiratory_system_inflammati | 1.40502113 |
| 44 | MP0003195_calcinosis | 1.40307301 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.35386412 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.32265454 |
| 47 | MP0004484_altered_response_of | 1.31963568 |
| 48 | MP0008260_abnormal_autophagy | 1.28081636 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.25304257 |
| 50 | MP0010307_abnormal_tumor_latency | 1.20902851 |
| 51 | MP0002429_abnormal_blood_cell | 1.19351689 |
| 52 | MP0002419_abnormal_innate_immunity | 1.18802427 |
| 53 | MP0000427_abnormal_hair_cycle | 1.18699990 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.12515848 |
| 55 | MP0003436_decreased_susceptibility_to | 1.09882650 |
| 56 | MP0002006_tumorigenesis | 1.09580878 |
| 57 | MP0004147_increased_porphyrin_level | 1.09093182 |
| 58 | MP0009697_abnormal_copulation | 1.08508485 |
| 59 | MP0009115_abnormal_fat_cell | 1.08294106 |
| 60 | MP0001851_eye_inflammation | 1.06893723 |
| 61 | MP0005408_hypopigmentation | 1.06545412 |
| 62 | MP0005310_abnormal_salivary_gland | 1.05141818 |
| 63 | MP0005253_abnormal_eye_physiology | 1.04525119 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.03058063 |
| 65 | MP0001790_abnormal_immune_system | 1.02988011 |
| 66 | MP0005387_immune_system_phenotype | 1.02988011 |
| 67 | MP0006054_spinal_hemorrhage | 1.02123785 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.02102513 |
| 69 | MP0008877_abnormal_DNA_methylation | 0.99481366 |
| 70 | MP0005025_abnormal_response_to | 0.97384370 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.96468212 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.96468212 |
| 73 | MP0002019_abnormal_tumor_incidence | 0.95870508 |
| 74 | MP0009764_decreased_sensitivity_to | 0.95773499 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95561094 |
| 76 | MP0003077_abnormal_cell_cycle | 0.91959415 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.90711997 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 0.86713320 |
| 79 | MP0003111_abnormal_nucleus_morphology | 0.83766322 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.82907998 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.81269851 |
| 82 | MP0002075_abnormal_coat/hair_pigmentati | 0.81094238 |
| 83 | MP0005334_abnormal_fat_pad | 0.80246559 |
| 84 | MP0001853_heart_inflammation | 0.76021696 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.74553753 |
| 86 | MP0003787_abnormal_imprinting | 0.74069853 |
| 87 | MP0005266_abnormal_metabolism | 0.73514096 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.72631952 |
| 89 | MP0003632_abnormal_nervous_system | 0.71559910 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.71408217 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.70945565 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.69964065 |
| 93 | MP0005647_abnormal_sex_gland | 0.69954260 |
| 94 | MP0001324_abnormal_eye_pigmentation | 0.69756506 |
| 95 | MP0004883_abnormal_blood_vessel | 0.68673326 |
| 96 | MP0008873_increased_physiological_sensi | 0.68288278 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.67984657 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.66904667 |
| 99 | MP0009785_altered_susceptibility_to | 0.65303696 |
| 100 | MP0005621_abnormal_cell_physiology | 0.65259264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.75473578 |
| 2 | T lymphocytopenia (HP:0005403) | 4.62097927 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.14160059 |
| 4 | Papillary thyroid carcinoma (HP:0002895) | 3.93268773 |
| 5 | Thyroiditis (HP:0100646) | 3.35338357 |
| 6 | Abnormality of the fingertips (HP:0001211) | 3.17785569 |
| 7 | Colitis (HP:0002583) | 3.07472680 |
| 8 | Optic neuritis (HP:0100653) | 3.06483789 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.06483789 |
| 10 | Subacute progressive viral hepatitis (HP:0006572) | 3.06373010 |
| 11 | IgA deficiency (HP:0002720) | 3.04648338 |
| 12 | Abnormality of T cells (HP:0002843) | 3.04493970 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.00593551 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 2.97849807 |
| 15 | Stomach cancer (HP:0012126) | 2.97591842 |
| 16 | Fair hair (HP:0002286) | 2.91630816 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83625275 |
| 18 | Submucous cleft hard palate (HP:0000176) | 2.80144266 |
| 19 | IgM deficiency (HP:0002850) | 2.75256995 |
| 20 | Arterial thrombosis (HP:0004420) | 2.75106732 |
| 21 | Homocystinuria (HP:0002156) | 2.74831778 |
| 22 | Abnormality of homocysteine metabolism (HP:0010919) | 2.74831778 |
| 23 | IgG deficiency (HP:0004315) | 2.71460009 |
| 24 | Volvulus (HP:0002580) | 2.68446695 |
| 25 | Fatigue (HP:0012378) | 2.67067978 |
| 26 | Prominent nose (HP:0000448) | 2.64755754 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.64540017 |
| 28 | Abnormality of the columella (HP:0009929) | 2.63026184 |
| 29 | Generalized hypopigmentation of hair (HP:0011358) | 2.59915337 |
| 30 | Acute myeloid leukemia (HP:0004808) | 2.59412478 |
| 31 | Eosinophilia (HP:0001880) | 2.57093806 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56049864 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.52256903 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.51110593 |
| 35 | Myositis (HP:0100614) | 2.50814564 |
| 36 | Abnormality of the nasal septum (HP:0000419) | 2.48770564 |
| 37 | Granulocytopenia (HP:0001913) | 2.48658355 |
| 38 | Thyroid carcinoma (HP:0002890) | 2.45919958 |
| 39 | Orchitis (HP:0100796) | 2.45188231 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38785757 |
| 41 | Severe combined immunodeficiency (HP:0004430) | 2.36787673 |
| 42 | Clumsiness (HP:0002312) | 2.35854718 |
| 43 | Encephalitis (HP:0002383) | 2.34976746 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.34665280 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34079606 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34079606 |
| 47 | Recurrent viral infections (HP:0004429) | 2.32980697 |
| 48 | Viral hepatitis (HP:0006562) | 2.29185952 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.27549306 |
| 50 | Acute hepatic failure (HP:0006554) | 2.27439930 |
| 51 | Abnormality of chromosome stability (HP:0003220) | 2.27199505 |
| 52 | Leukocytosis (HP:0001974) | 2.26121828 |
| 53 | Dislocated radial head (HP:0003083) | 2.24834626 |
| 54 | Glucose intolerance (HP:0000833) | 2.22037728 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.21589287 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.20850687 |
| 57 | Abnormality of the radial head (HP:0003995) | 2.20451486 |
| 58 | Anorexia (HP:0002039) | 2.18481385 |
| 59 | Conjunctival telangiectasia (HP:0000524) | 2.17119992 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.11990160 |
| 61 | Blue irides (HP:0000635) | 2.10266710 |
| 62 | Stomatitis (HP:0010280) | 2.08275007 |
| 63 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.07298771 |
| 64 | Micronodular cirrhosis (HP:0001413) | 2.06904338 |
| 65 | Gingival bleeding (HP:0000225) | 2.05790493 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.05242570 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.05170086 |
| 68 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.03768353 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.03113430 |
| 70 | Tented upper lip vermilion (HP:0010804) | 2.00666283 |
| 71 | Clubbing of toes (HP:0100760) | 1.98371705 |
| 72 | Sandal gap (HP:0001852) | 1.98245786 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 1.98222039 |
| 74 | Recurrent skin infections (HP:0001581) | 1.95767379 |
| 75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95256995 |
| 76 | Oligodactyly (hands) (HP:0001180) | 1.94285185 |
| 77 | Abnormality of the labia majora (HP:0012881) | 1.89408205 |
| 78 | Recurrent bronchitis (HP:0002837) | 1.89265108 |
| 79 | Abnormal glucose tolerance (HP:0001952) | 1.88560261 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 1.86212986 |
| 81 | Hematochezia (HP:0002573) | 1.84846754 |
| 82 | Cutis marmorata (HP:0000965) | 1.83812139 |
| 83 | Absent speech (HP:0001344) | 1.82114643 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 1.79900967 |
| 85 | Hyperalaninemia (HP:0003348) | 1.79900967 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79900967 |
| 87 | Chromsome breakage (HP:0040012) | 1.78448737 |
| 88 | Portal hypertension (HP:0001409) | 1.78066929 |
| 89 | Attenuation of retinal blood vessels (HP:0007843) | 1.77932964 |
| 90 | Birth length less than 3rd percentile (HP:0003561) | 1.77444670 |
| 91 | Constricted visual fields (HP:0001133) | 1.77015393 |
| 92 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.76600874 |
| 93 | Esophageal varix (HP:0002040) | 1.76286909 |
| 94 | Premature graying of hair (HP:0002216) | 1.75658526 |
| 95 | Long eyelashes (HP:0000527) | 1.74960594 |
| 96 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.74687015 |
| 97 | Protruding tongue (HP:0010808) | 1.73158759 |
| 98 | Chronic hepatic failure (HP:0100626) | 1.72353810 |
| 99 | White forelock (HP:0002211) | 1.69889757 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 1.69570374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.15339076 |
| 2 | MAP4K2 | 3.59961836 |
| 3 | FRK | 3.53917473 |
| 4 | BLK | 3.27441654 |
| 5 | ACVR1B | 3.26514317 |
| 6 | JAK3 | 2.44526756 |
| 7 | TXK | 2.26550587 |
| 8 | PIK3CG | 2.26405157 |
| 9 | AKT3 | 2.23540896 |
| 10 | GRK6 | 1.95433102 |
| 11 | FGR | 1.95400302 |
| 12 | MAP2K3 | 1.92872681 |
| 13 | PDK2 | 1.69985339 |
| 14 | SGK2 | 1.62141464 |
| 15 | TEC | 1.54658524 |
| 16 | MAP4K1 | 1.53187367 |
| 17 | ZAK | 1.50307420 |
| 18 | PIM1 | 1.45118289 |
| 19 | BTK | 1.44310384 |
| 20 | NEK6 | 1.41997773 |
| 21 | BRD4 | 1.38954886 |
| 22 | MAP3K7 | 1.37978994 |
| 23 | FES | 1.36698071 |
| 24 | MARK3 | 1.36530461 |
| 25 | STK4 | 1.35097809 |
| 26 | MELK | 1.34860443 |
| 27 | WNK1 | 1.34632807 |
| 28 | BMPR1B | 1.33956629 |
| 29 | BRSK2 | 1.30961962 |
| 30 | CAMKK2 | 1.29979880 |
| 31 | STK38L | 1.24557446 |
| 32 | SYK | 1.23206146 |
| 33 | MAP3K3 | 1.21381092 |
| 34 | PTK2B | 1.20712646 |
| 35 | ITK | 1.18727678 |
| 36 | RPS6KB2 | 1.17407767 |
| 37 | IKBKE | 1.17267209 |
| 38 | TLK1 | 1.16994285 |
| 39 | CDK12 | 1.16017078 |
| 40 | RAF1 | 1.12449542 |
| 41 | TRPM7 | 1.12407900 |
| 42 | SGK3 | 1.08417051 |
| 43 | STK38 | 1.05676788 |
| 44 | SGK494 | 0.99562519 |
| 45 | SGK223 | 0.99562519 |
| 46 | MARK2 | 0.99033916 |
| 47 | JAK1 | 0.98383822 |
| 48 | HCK | 0.97853541 |
| 49 | NUAK1 | 0.97556290 |
| 50 | CDK3 | 0.96621163 |
| 51 | MAPK11 | 0.93068104 |
| 52 | IKBKB | 0.88021263 |
| 53 | CAMK4 | 0.83280763 |
| 54 | MAP3K14 | 0.82010729 |
| 55 | PRKAA2 | 0.81346137 |
| 56 | LCK | 0.79418333 |
| 57 | BMPR2 | 0.76339645 |
| 58 | LYN | 0.72748200 |
| 59 | EIF2AK3 | 0.72468375 |
| 60 | STK10 | 0.69628540 |
| 61 | STK11 | 0.68817448 |
| 62 | CAMK1D | 0.68279751 |
| 63 | ZAP70 | 0.65830000 |
| 64 | NLK | 0.62338284 |
| 65 | KIT | 0.61840828 |
| 66 | CAMK1 | 0.60925101 |
| 67 | MTOR | 0.60825246 |
| 68 | OBSCN | 0.59735784 |
| 69 | CDK6 | 0.58484774 |
| 70 | JAK2 | 0.57286163 |
| 71 | EIF2AK1 | 0.56497834 |
| 72 | SGK1 | 0.54950648 |
| 73 | CDK4 | 0.54550772 |
| 74 | FGFR3 | 0.53074233 |
| 75 | EGFR | 0.52683714 |
| 76 | IRAK4 | 0.52680198 |
| 77 | CSK | 0.51121836 |
| 78 | CAMK1G | 0.48915555 |
| 79 | CHUK | 0.48376858 |
| 80 | PLK2 | 0.46366323 |
| 81 | MST4 | 0.46118614 |
| 82 | TGFBR2 | 0.44214068 |
| 83 | NEK9 | 0.43384325 |
| 84 | ADRBK1 | 0.42008211 |
| 85 | ERBB3 | 0.41596791 |
| 86 | TYK2 | 0.41487708 |
| 87 | PRKAA1 | 0.41103524 |
| 88 | MAP3K6 | 0.40955076 |
| 89 | OXSR1 | 0.40885215 |
| 90 | PDK1 | 0.40290539 |
| 91 | MATK | 0.40284455 |
| 92 | RPS6KA5 | 0.39296167 |
| 93 | RPS6KB1 | 0.37782273 |
| 94 | PIK3CA | 0.34339160 |
| 95 | PRKCQ | 0.33025566 |
| 96 | ATR | 0.32913124 |
| 97 | MAP3K2 | 0.32097707 |
| 98 | MAP2K2 | 0.31649830 |
| 99 | ERBB2 | 0.31320477 |
| 100 | MAP2K1 | 0.31013811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.83023041 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.45633035 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03646304 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90305204 |
| 5 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89638133 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88860893 |
| 7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.86081472 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.82799655 |
| 9 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.80328013 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77043666 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71365226 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69893144 |
| 13 | Alcoholism_Homo sapiens_hsa05034 | 1.68578575 |
| 14 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.67373507 |
| 15 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.66078135 |
| 16 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.63951084 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.62979434 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58296124 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.57693753 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.57047972 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52872165 |
| 22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.47438636 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43468094 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39034431 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34134365 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33175155 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27935196 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27475823 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25826115 |
| 30 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.21919755 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20893028 |
| 32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20822583 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.20796158 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20466609 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16057677 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12759569 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.10731364 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.09372684 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.06376500 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02657220 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02235450 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01523421 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00941075 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00229598 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 0.99334910 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97729806 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97660002 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 0.97005204 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95777528 |
| 50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94879902 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.93738214 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.92770829 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92463357 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92436765 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92324729 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91277230 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90578841 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89105064 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87610627 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87336540 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87027684 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.86391854 |
| 63 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83476731 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.80022976 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77473906 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.77238677 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75664136 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75657713 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74044876 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71813617 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.71721216 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71470379 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71380866 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69024216 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68278979 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.67310212 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66974078 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.64230535 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59556125 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58387613 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58184708 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56753528 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53125074 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.50406697 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50364460 |
| 86 | Cell cycle_Homo sapiens_hsa04110 | 0.50295224 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49552302 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46026929 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45436963 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45375525 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45153748 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44042808 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42995341 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42580698 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40500810 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40141100 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39645499 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39633226 |
| 99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39520019 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37754196 |

